Eynat Kedem

Summary

Country: Israel

Publications

  1. ncbi Iatrogenic Cushing's syndrome due to coadministration of ritonavir and inhaled budesonide in an asthmatic human immunodeficiency virus infected patient
    Eynat Kedem
    Institute of Clinical Immunology, Allergy and AIDS, Rambam Health Care Campus, Haifa, Israel
    J Asthma 47:830-1. 2010
  2. ncbi Effect of HAART on salivary composition and oxidative profile in HIV-infected patients
    Eduardo Shahar
    Institute of Allergy, Clinical Immunology and AIDS, Rambam Medical Center, Haifa, Israel
    Curr HIV Res 6:447-51. 2008
  3. ncbi Successful desensitization protocol for hypersensitivity reaction caused by sunitinib in a patient with a gastrointestinal stromal tumor
    Gil Bar-Sela
    Division of Oncology, Rambam Health Care Campus and Faculty of Medicine, Technion Israel Institute of Technology, Haifa, Israel
    Jpn J Clin Oncol 40:163-5. 2010
  4. ncbi Absence of APOL1 risk variants protects against HIV-associated nephropathy in the Ethiopian population
    Doron M Behar
    Molecular Medicine Laboratory, Rambam Health Care Campus, Haifa, Israel
    Am J Nephrol 34:452-9. 2011

Collaborators

Detail Information

Publications4

  1. ncbi Iatrogenic Cushing's syndrome due to coadministration of ritonavir and inhaled budesonide in an asthmatic human immunodeficiency virus infected patient
    Eynat Kedem
    Institute of Clinical Immunology, Allergy and AIDS, Rambam Health Care Campus, Haifa, Israel
    J Asthma 47:830-1. 2010
    ..It is well known in asthmatic human immunodeficiency virus (HIV)-infected patients treated with inhaled fluticasone with ritonavir-containing antiretroviral regimen (cART)...
  2. ncbi Effect of HAART on salivary composition and oxidative profile in HIV-infected patients
    Eduardo Shahar
    Institute of Allergy, Clinical Immunology and AIDS, Rambam Medical Center, Haifa, Israel
    Curr HIV Res 6:447-51. 2008
    ..Salivary collection is simple, non-invasive and not associated with risk of infection spread. Antioxidants in HIV patients may be recommended, as well as local oral means aimed at resuming salivary functions compromised in HIV patients...
  3. ncbi Successful desensitization protocol for hypersensitivity reaction caused by sunitinib in a patient with a gastrointestinal stromal tumor
    Gil Bar-Sela
    Division of Oncology, Rambam Health Care Campus and Faculty of Medicine, Technion Israel Institute of Technology, Haifa, Israel
    Jpn J Clin Oncol 40:163-5. 2010
    ..Oral desensitization appears to be an option for patients with hypersensitivity type I to sunitinib and may permit its safe administration to patients who experience HSR to this life-prolonging medication...
  4. ncbi Absence of APOL1 risk variants protects against HIV-associated nephropathy in the Ethiopian population
    Doron M Behar
    Molecular Medicine Laboratory, Rambam Health Care Campus, Haifa, Israel
    Am J Nephrol 34:452-9. 2011
    ....